Dr. John Kellie

Bioanalysis, Immunogenicity & Biomarkers, GSK

Dr. John Kellie on Developing a Whole Molecule Approach for Biopharmaceutical Analysis

Dr. John Kellie, Associate Fellow, Bioanalysis, Immunogenicity and Biomarkers, GSK, describes a technique for the quantitation of whole molecule biopharmaceutical candidates using high-resolution mass spec.

LIKE 0


Dr. John Kellie
Health Sciences Mass Spectrometry

Dr. John Kellie

Biography

Dr. John Kellie, Associate Fellow, Bioanalysis, Immunogenicity and Biomarkers, GSK More

Dr. John Kellie

Bioanalysis, Immunogenicity & Biomarkers, GSK

Dr. John Kellie, Associate Fellow, Bioanalysis, Immunogenicity and Biomarkers at GlaxoSmithKline